• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides

Introduction to 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide (CAS No. 214210-15-8)

3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide, identified by the Chemical Abstracts Service Number (CAS No.) 214210-15-8, is a specialized organic compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound belongs to the class of sulfonamides, which are well-known for their broad spectrum of biological activities and utility in drug development. The structural features of this molecule, particularly the presence of both bromine and trifluoromethyl substituents, contribute to its unique chemical properties and potential applications in synthetic chemistry and pharmacology.

The sulfonamide functional group in 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide plays a crucial role in its biological interactions. Sulfonamides are widely recognized for their ability to act as inhibitors of enzymes and receptors, making them valuable scaffolds for the design of therapeutic agents. The introduction of a bromine atom at the 3-position and a trifluoromethyl group at the 5-position further modulates the electronic and steric properties of the molecule, enhancing its reactivity and binding affinity. These modifications are strategically employed to optimize pharmacokinetic profiles and improve target specificity, which are critical factors in drug discovery.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to explore the structural-activity relationships (SAR) of compounds like 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide with greater precision. Studies have demonstrated that the trifluoromethyl group, in particular, can significantly enhance the metabolic stability of drug candidates by resisting oxidative degradation. This property is particularly valuable in the development of long-acting pharmaceuticals that require minimal dosing frequency. Additionally, the bromine substituent can serve as a handle for further chemical modifications, allowing for the synthesis of derivatives with tailored biological activities.

In the realm of medicinal chemistry, 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide has been investigated for its potential as an intermediate in the synthesis of novel sulfonamide-based drugs. The compound’s versatility makes it suitable for various applications, including the development of antimicrobial agents, anti-inflammatory drugs, and even kinase inhibitors. For instance, sulfonamides have shown promise in targeting bacterial infections by inhibiting enzymes essential for bacterial metabolism. The structural motif present in 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide aligns well with this mode of action, suggesting its utility in combating resistant bacterial strains.

The synthesis of 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide involves multi-step organic reactions that highlight its synthetic accessibility while maintaining high purity standards. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitutions, are often employed to introduce the bromine and trifluoromethyl groups with high efficiency. These techniques not only ensure regioselectivity but also minimize unwanted side products, which is crucial for pharmaceutical-grade intermediates. The growing emphasis on green chemistry principles has also influenced synthetic routes toward 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide, promoting solvent-free reactions and catalytic processes that reduce environmental impact.

From a biological perspective, the combination of bromine and trifluoromethyl substituents in 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide imparts distinct physicochemical properties that influence its interaction with biological targets. The electron-withdrawing nature of the trifluoromethyl group increases lipophilicity, while the bromine atom enhances polarizability. These characteristics are often exploited to achieve optimal solubility and membrane permeability, key factors in drug absorption and distribution. Furthermore, sulfonamides are known to exhibit favorable interactions with hydrogen bond donors and acceptors, which is critical for binding to biological macromolecules such as proteins and enzymes.

Recent research has also explored the role of 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide in material science applications beyond pharmaceuticals. Its unique electronic properties make it a candidate for use in organic electronics, such as light-emitting diodes (OLEDs) and photovoltaic cells. The presence of both electron-donating (sulfonamide) and electron-withdrawing (trifluoromethyl) groups allows for fine-tuning of charge transport properties, which is essential for optimizing device performance. Additionally, derivatives of this compound have been investigated for their potential use as ligands in catalysis, where they can facilitate various transformations by coordinating with transition metals.

The future prospects for 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide are promising, with ongoing studies focusing on expanding its utility across multiple domains. Innovations in drug discovery technologies continue to leverage sulfonamides as privileged scaffolds due to their proven efficacy and structural flexibility. As computational methods advance, virtual screening campaigns are being conducted to identify novel derivatives of 3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide with enhanced biological activity profiles. Such efforts aim to accelerate the development pipeline for next-generation therapeutics targeting complex diseases.

In conclusion,3-bromo-5-(trifluoromethyl)benzene-1-sulfonamide (CAS No. 214210-15-8) represents a versatile compound with significant potential across pharmaceuticals and materials science. Its unique structural features—comprising both bromine and trifluoromethyl substituents—contribute to its broad applicability by modulating electronic properties and enhancing binding affinity towards biological targets. As research progresses，this compound is expected to play an increasingly important role in addressing unmet medical needs while driving innovation in synthetic chemistry。

• 830-43-3(4-(trifluoromethyl)benzene-1-sulfonamide)
• 351003-61-7(2-bromo-5-(trifluoromethyl)benzene-1-sulfonamide)
• 951884-65-4(N,N-Dimethyl 3-bromo-5-trifluoromethylbenzenesulfonamide)
• 351003-62-8(4-Bromo-2-(trifluoromethyl)benzenesulfonamide)
• 672-58-2(3-(trifluoromethyl)benzene-1-sulfonamide)
• 1462968-70-2(5-Bromo-2-(trifluoromethyl)benzenesulfonamide)
• 951884-79-0(N-Ethyl 3-bromo-5-trifluoromethylbenzenesulfonamide)
• 351003-63-9(2-Bromo-4-(trifluoromethyl)benzenesulfonamide)
• 351003-64-0(4-Bromo-3-(trifluoromethyl)benzenesulfonamide)
• 39213-22-4(3,5-bis(Trifluoromethyl)benzene-1-sulfonamide)